EUVIMEDEUVIMED entdecken
Crossref

Predictors of Stent Dysfunction in Malignant Esophageal Strictures: A 10-Year Multicenter Retrospective Study

Ö Çelebi, C Jürgensen, M Sigal, A Adler, K Kouladouros, I Levenfus, F Tacke, T Kleemann, Q T Tran, M Razpotnik

Endoscopy · 01.06.2026 · 58 (S 03 S 03) · S843-S844

DOI: 10.1055/s-0046-1822322 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.06.2026. Verfasst von Ö Çelebi und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Malignant esophageal strictures are frequently managed using self-expanding metal stents (SEMS). Stent-related adverse events, especially stent dysfunction, pose a significant challenge and often require reintervention. The aim of this study was to determine predictors of stent dysfunction in malignant esophageal strictures ([ Table 1 ]). Table 1 Factors Univariable Analysis Multivariable Analysis OR (95% CI) p-value OR (95% CI) p-value Age≥65 Years 2,2 (1,2–4,4) 0,016 2,4 (1,1–5,2) 0,023 Female Sex 0,7 (0,3-1,5) 0,397 Cardiac Comorbidity 2,3 (1,2–4,4) 0,008 Pulmonary Comorbidity 0,8 (0,4-1,8) 0,637 Hepatic Comorbidity 2,3 (0,6-8,3) 0,208 Renal Comorbidity 1,4 (0,5-3,6) 0,495 Dysphagia Score>1 0,7 (0,3-1,3) 0,180 Adenocarcinoma 1,8 (1,0-3,5) 0,057 Upper Esophagus 0,9 (0,3-2,5) 0,875 Middle Esophagus 0,6 (0,3-1,3) 0,196 Lower Esophagus 1,6 (0,9-3,2) 0,129 GE Junction 2,1 (1,1-4,0) 0,019 Esophagogastrostomy 0,5 (0,1-2,5) 0,426 Esophagojejunostomy 5,8 (1,1-31,0) 0,039 9,5 (1,6–57,9) 0,014 Stricture Length≤20mm 0,8 (0,3-2,4) 0,682 Stricture Diameter≥9mm 2,2 (1,2-4,2) 0,012 2,2 (1,1–4,5) 0,024 Fully Covered SEMS 2,4 (1,3-4,5) 0,008 2,5 (1,2–4,9) 0,011 Stent Length≤110 mm 1,6 (0,8-3,0) 0,181 Stent Diameter≤22mm 2,3 (1,1–4,8) 0,033 Methods This multicenter, retrospective study included patients with malignant esophageal strictures who were treated with SEMS at three university hospitals between January 2014 and December 2023. The clinical endpoint was the occurrence of stent dysfunction, defined as impairment of lumen patency due to ingrowth, overgrowth, bolus, or dislocation. Patient characteristics, stricture features, and procedural factors were analyzed.

Results

In total, 187 patients were included in the study. The mean age was 67±11 years, and 78% of the patients were male. The overall complication rate was 43%, stent dysfunction occurred in 32% of patients. Univariable logistic regression analysis showed that patients over 65 years (OR 2,2; 95% CI 1,2–4,4; p=0,016) or with cardiac comorbidity (OR 2,3; 95% CI 1,2–4,4; p=0,008) experienced stent dysfunction significantly more often. Stents placed at the gastroesophageal (GE) junction (OR 2,1; 95% CI 1,1–4,0; p=0,019) or an esophagojejunal anastomosis (OR 5,8; 95% CI 1,1–31,0; p=0,039) were more prone to dysfunction. The risk of stent dysfunction was higher with a stricture diameter≥9 mm (OR 2,2; 95% CI 1,2–4,2; p=0,012), and also when fully covered (OR 2,4; 95% CI 1,3–4,5; p=0,008) or small-diameter SEMS≤22mm (OR 2,3; 95% CI 1,1–4,8; p=0,033) were used. In multivariable analysis, age≥65 years (OR 2,4; 95% CI 1,1–5,2; p=0,023), the presence of an esophagojejunostomy (OR 9,5; 95% CI 1,6–57,9; p=0,014), a stricture diameter≥9 mm (OR 2,2; 95% CI 1,1–4,5; p=0,024), and the use of a fully covered SEMS (OR 2,5; 95% CI 1,2–4,9; p=0,011) were significantly associated with an increased risk of stent dysfunction.

Conclusions

A stricture diameter≥9 mm, the use of fully covered SEMS, the presence of an esophagojejunostomy, and older age were identified as independent predictors of stent dysfunction in malignant esophageal strictures. These factors should guide stent choice and individualized therapy. Publication History Article published online: 06 June 2026 © 2026. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Zitieren

APA

Çelebi, Ö., Jürgensen, C., Sigal, M., Adler, A., Kouladouros, K., Levenfus, I., Tacke, F., Kleemann, T., Tran, Q. T., & Razpotnik, M. (2026). Predictors of Stent Dysfunction in Malignant Esophageal Strictures: A 10-Year Multicenter Retrospective Study. Endoscopy, 58(S 03 S 03), S843-S844. https://doi.org/10.1055/s-0046-1822322

Vancouver

Çelebi Ö, Jürgensen C, Sigal M, Adler A, Kouladouros K, Levenfus I, et al. Predictors of Stent Dysfunction in Malignant Esophageal Strictures: A 10-Year Multicenter Retrospective Study. Endoscopy. 2026;58(S 03 S 03):S843-S844. doi:10.1055/s-0046-1822322

BibTeX
@article{elebi2026,
  author = {Çelebi, Ö and Jürgensen, C and Sigal, M and Adler, A and Kouladouros, K and Levenfus, I and Tacke, F and Kleemann, T and Tran, Q T and Razpotnik, M},
  title = {Predictors of Stent Dysfunction in Malignant Esophageal Strictures: A 10-Year Multicenter Retrospective Study},
  journal = {Endoscopy},
  year = {2026},
  volume = {58},
  number = {S 03 S 03},
  pages = {S843--S844},
  doi = {10.1055/s-0046-1822322}
}
Kostenlos starten →